Bestrophins and retinopathies

Area of Science:

• Ophthalmology
• Genetics
• Cell Biology

Background:

• Best vitelliform macular dystrophy (BVMD), or Best's disease, is an inherited juvenile macular degeneration.
• It is characterized by subretinal yellow pigment accumulation and a reduced electro-oculogram light peak (LP).
• Over 100 mutations in human bestrophin-1 (hBest1) are linked to BVMD and other retinopathies, but its precise function remains unclear.

Purpose of the Study:

• To review the relationship between hBest1 dysfunction and the characteristic symptoms of BVMD.
• To elucidate the mechanisms underlying pigment and fluid accumulation in BVMD.
• To explore the potential roles of hBest1 as a bicarbonate or volume-regulated chloride channel.

Main Methods:

• Literature review focusing on hBest1 function and BVMD pathology.
• Analysis of existing research on hBest1 mutations and their clinical manifestations.
• Synthesis of data linking hBest1 channel activity to retinal pigment epithelium (RPE) cell function.

Main Results:

• hBest1 exhibits diverse functions, including Ca2+-activated Cl- channel, Ca2+ channel regulator, volume-regulated Cl- channel, and HCO3- channel activity.
• Dysfunction of hBest1, particularly as a HCO3- or volume-regulated Cl- channel, is implicated in BVMD.
• This dysfunction may impair subretinal fluid regulation and photoreceptor outer segment phagocytosis by RPE cells.

Conclusions:

• hBest1 dysfunction is a key factor in the pathogenesis of BVMD.
• Altered hBest1 channel activity likely disrupts RPE function, leading to pigment and fluid accumulation.
• Further research into hBest1's specific channel roles is crucial for understanding and potentially treating BVMD.